Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Melatonin, a pineal hormone, influences cell-mediated immunity.
• Its impact on the humoral immune system, particularly B lymphocyte development, remains largely uncharacterized.
• Apoptosis is a key regulatory process in B lymphocyte development within bone marrow.

Purpose of the Study:

• To investigate the effects of melatonin on in vivo B lymphocyte development in mouse bone marrow.
• To determine if melatonin influences the rate of apoptosis in precursor B cells.
• To assess the potential of melatonin to modulate humoral immunity.

Main Methods:

• Mice were fed either a melatonin-containing or control diet for 16 days.
• Bone marrow was analyzed using double immunofluorescence labeling and flow cytometry.
• Apoptotic rates and phenotypically defined B cell populations (precursor and mature) were quantified.

Main Results:

• Melatonin treatment markedly reduced apoptosis in large pre-B cells, including those expressing the pre-B-cell receptor.
• An associated increase in the absolute number of large pre-B cells was observed in melatonin-treated mice.
• Apoptosis rates in earlier precursor B cells and mature B lymphocytes were not significantly affected by melatonin.

Conclusions:

• Oral administration of melatonin promotes the survival of precursor B cells in mouse bone marrow.
• Melatonin may enhance the pool of newly formed B cells involved in humoral immune responses.
• These findings highlight a potential role for melatonin in regulating humoral immunity through B cell survival.